For instance in a case report, Donepezil, a cholinesterase inhibitor used clinically to ameliorate memory-related cognitive deficits in Alzheimer’s disease, given to one alcoholic patient who presented with cognitive impairment without any typical findings of Alzheimer’s disease showed improvement in cognitive functions (Kim et al., 2004). Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.